GlassScriptPhysician profile
Henry Martinez
NPI 1417937053
$2,342.85
in general payments reported to CMS, 2019-2025
14 companies · $408 in 2025
The $408 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $445 · 2022: $542 · 2023: $626 · 2024: $321 · 2025: $408.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,356.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,355.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $543.46 | 2021-2025 | Trelegy Ellipta, Nucala |
| Genentech USA, INC. | $348.15 | 2022-2025 | Xolair, Tecentriq |
| Astrazeneca Pharmaceuticals LP | $347.13 | 2021-2025 | Tezspire, Fasenra, Airsupra |
| Genzyme Corporation | $303.19 | 2021-2025 | |
| Regeneron Healthcare Solutions, INC. | $240.03 | 2022-2025 | Dupixent |
| Takeda Pharmaceuticals U.S.A., INC. | $218.57 | 2021-2024 | Takhzyro |
| Novartis Pharmaceuticals Corporation | $169.43 | 2023-2025 | Xolair |
| Edwards Lifesciences Corporation | $50.00 | 2022 | |
| Abbvie INC. | $31.07 | 2023 | |
| Aimmune Therapeutics, INC. | $23.43 | 2022 | |
| Optinose US, INC. | $20.32 | 2022 | |
| Blueprint Medicines Corporation | $17.93 | 2025 | Ayvakit |
| Pharming Healthcare, INC. | $15.92 | 2022 | |
| Organon LLC | $14.22 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Henry Martinez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.